NYSE: EG
Everest Group
Financials · Fire, Marine & Casualty Insurance
52-week range
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$13.5B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.85B |
| FY2017, ended Dec 31, 2017 | $9.04B |
| FY2018, ended Dec 31, 2018 | $8.86B |
| FY2019, ended Dec 31, 2019 | $11.3B |
| FY2020, ended Dec 31, 2020 | $9.36B |
| FY2021, ended Dec 31, 2021 | $10.8B |
| FY2022, ended Dec 31, 2022 | $13.0B |
| FY2023, ended Dec 31, 2023 | $15.3B |
| FY2024, ended Dec 31, 2024 | $15.6B |
| FY2025, ended Dec 31, 2025 | $13.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $13.5B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$16.2B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.79B |
| FY2017, ended Dec 31, 2017 | $6.62B |
| FY2018, ended Dec 31, 2018 | $7.36B |
| FY2019, ended Dec 31, 2019 | $8.23B |
| FY2020, ended Dec 31, 2020 | $9.60B |
| FY2021, ended Dec 31, 2021 | $11.9B |
| FY2022, ended Dec 31, 2022 | $12.1B |
| FY2023, ended Dec 31, 2023 | $14.6B |
| FY2024, ended Dec 31, 2024 | $17.3B |
| FY2025, ended Dec 31, 2025 | $17.5B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $16.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$1.89B
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $792M |
| FY2017, ended Dec 31, 2017 | $273M |
| FY2018, ended Dec 31, 2018 | −$126M |
| FY2019, ended Dec 31, 2019 | $766M |
| FY2020, ended Dec 31, 2020 | $262M |
| FY2021, ended Dec 31, 2021 | $1.38B |
| FY2022, ended Dec 31, 2022 | $597M |
| FY2023, ended Dec 31, 2023 | $2.52B |
| FY2024, ended Dec 31, 2024 | $1.37B |
| FY2025, ended Dec 31, 2025 | $1.59B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.89B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$987M
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $482M |
| FY2017, ended Dec 31, 2017 | $635M |
| FY2018, ended Dec 31, 2018 | $656M |
| FY2019, ended Dec 31, 2019 | $808M |
| FY2020, ended Dec 31, 2020 | $802M |
| FY2021, ended Dec 31, 2021 | $1.44B |
| FY2022, ended Dec 31, 2022 | $1.40B |
| FY2023, ended Dec 31, 2023 | $1.44B |
| FY2024, ended Dec 31, 2024 | $1.55B |
| FY2025, ended Dec 31, 2025 | $1.32B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $987M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.No figures for this period in the company’s filings.
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 9.4% since 2016.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.37.0M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 40.9M |
| FY2017, ended Dec 31, 2017 | 40.8M |
| FY2018, ended Dec 31, 2018 | 40.7M |
| FY2019, ended Dec 31, 2019 | 40.8M |
| FY2020, ended Dec 31, 2020 | 40.0M |
| FY2021, ended Dec 31, 2021 | 39.3M |
| FY2022, ended Dec 31, 2022 | 39.2M |
| FY2023, ended Dec 31, 2023 | 43.4M |
| FY2024, ended Dec 31, 2024 | 42.9M |
| FY2025, ended Dec 31, 2025 | 40.4M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 37.0M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.Net: $1.52B more bought back than issued
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $386M | $26.4M | $10.8M |
| FY2017, ended Dec 31, 2017 | $50.0M | $30.3M | — |
| FY2018, ended Dec 31, 2018 | $75.3M | $32.4M | — |
| FY2019, ended Dec 31, 2019 | $24.6M | $34.0M | — |
| FY2020, ended Dec 31, 2020 | $200M | $39.0M | — |
| FY2021, ended Dec 31, 2021 | $225M | $43.0M | $0 |
| FY2022, ended Dec 31, 2022 | $61.0M | $45.0M | $0 |
| FY2023, ended Dec 31, 2023 | $0 | $49.0M | $1.45B |
| FY2024, ended Dec 31, 2024 | $200M | $63.0M | $0 |
| FY2025, ended Dec 31, 2025 | $797M | $61.0M | $0 |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.59B | $76.0M | — |
Revenue (TTM)
$16.2B
−8.7% YoY
Net income (TTM)
$1.89B
+243% YoY
Cash
$987M
−35.9% YoY
Total debt
—
—
Valuation
At current price- Market Cap
- $15.2B
- P/E
- 8.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.9×
- Price / Book
- 1.1×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $16.2B
- Revenue Growth YoY
- −8.7%
- Revenue CAGR 3Y
- 13.2%
- Revenue CAGR 5Y
- 12.8%
- EPS Growth YoY
- 254%
- Net Income Growth YoY
- 243%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 11.7%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 12.8%
Earnings
Trailing 12 months- Net Income
- $1.89B
- EPS (diluted)
- $47.59
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $987M
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $62.1B
- Total Liabilities
- $47.8B
- Shareholders' Equity
- $14.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $1.21B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 1.5%
- Dividend / Share
- $6.00
- Beta (5Y)
- 0.26
Every ratio is calculated from the company’s reported figures.
Watch
Revenue fell 8.7% over the last year, to $16.2B.
Note
Net margin of 11.7% over the last 12 months.
Strength
Share count is down 11.8% in a year, from buybacks.
Written by fixed rules from the reported figures, not by a person or an AI.
Latest report
Pro10-Q for the quarter ended Sep 30, 2026 · filed Oct 30, 2026
The score and findings for the newest report are part of CoreStock Pro, coming soon. Every earlier report is free.
Score of each annual report
0 to 100 · 60 means nothing notable · tap a column for its details
2025 · 10-K53Some concerns
10-K for the fiscal year ended Dec 31, 2025
Filed Feb 26, 2026 · Read the filing on EDGAR
- Net income rose 15.9% to $1.6 billion on revenue up 1.2% to $17.5 billion, helped by smaller additions to reserves for older claims.
- Everest still added $657 million for prior-year claims, mostly US casualty, but the combined ratio improved to 98.6% from 102.3%.
- It bought up to $1.2 billion of protection against further growth in older North American claims and sold about $2 billion of retail insurance renewals to AIG.
- Reinsurance, its largest business, saw underwriting profit fall 17.7%, while Insurance still lost $541 million, though that loss roughly halved.
Business momentum
Mixed
“Underwriting gain (loss) $ 972 $ 1,181 $ 1,334 $ (209) (17.7) % $ (153) (11.5) %”
Outlook
Neutral
“Management generally expects annual positive cash flow from operations.”
Financial stress
Low
“We believe that these fixed maturity securities, in conjunction with the short-term investments and positive cash flow from operations, provide ample sources of liquidity for the expected payment of losses and LAE in the near future.”
Tone against the previous report
More positive
Red flags
- Medium
Other
“As noted above, each of A.M. Best, S&P and Moody’s has assigned a negative outlook to our financial strength ratings.”
- Medium
Other
“Our net income of $1.6 billion for the year ended December 31, 2025 is inclusive of unfavorable development of prior-year loss reserves of $657 million.”
Positives
Underwriting turned profitable overall, with the combined ratio falling below 100%
“Our combined ratio decreased by 3.7 points to 98.6% in 2025, compared to 102.3% in 2024.”
New reinsurance limits the cost of further growth in older North American claims
“The agreements reinsure potential adverse loss development for accident years 2024 and prior arising from substantially all of the Ceding Companies’ North American liabilities within the Insurance and Other segments (“Subject Business”) up to a gross limit of $1.2 billion.”
Investment income kept growing
“Net investment income increased by 8.7% to $2.1 billion in 2025, compared with net investment income of $2.0 billion in 2024.”
Concerns
Reserves for older US casualty claims needed increasing for a second straight year
“the Company increased its loss reserves by $657 million, pre-tax and net of reinsurance, primarily driven by net unfavorable development on prior year reserves from elevated loss experience in excess casualty and U.S. liability lines”
Insurance segment remains unprofitable, paying out far more than it earns in premiums
“Combined ratio 114.6 % 130.7 % 100.5 % (16.1) 30.1”
Operating cash flow fell sharply and premiums written declined
“Our net cash flows from operating activities were $3.1 billion and $5.0 billion for the years ended December 31, 2025 and 2024, respectively.”
New risks since the previous report
Negative outlook from all three rating agencies; a downgrade could hurt new business and trigger contract terminations
“A downgrade or withdrawal of any of these ratings could adversely affect our ability to market our reinsurance and insurance products, our ability to compete with other reinsurers and insurers and our ability to write new business”
Reliance on reinsurers behind the new protection for older claims paying what they owe
“The failure of one or more of our reinsurers, including but not limited to the counterparties to the adverse development cover reinsurance agreements, to honor their obligations to us in a timely fashion would impact our cash flow”
The sale of retail insurance renewal rights to AIG may not deliver expected benefits
“There can be no assurance that we will realize the anticipated economic, strategic or other benefits of the transaction.”
Possible group-wide supervision by Bermuda's regulator could change capital requirements and raise compliance costs
“Group supervision by the BMA, including any future holding company designation, could affect our prescribed capital requirements, the terms of current and future debt, intercompany capital transactions, ratings and may significantly increase our cost of regulatory compliance.”
Biggest risks named
- Claim reserves proving too low, especially in US casualty lines
- Large catastrophe losses, possibly worsened by climate change
- Credit rating downgrade after negative outlooks from all three agencies
- Rising claims costs from lawsuits and larger court awards
- Tax changes, including Bermuda's corporate tax and global minimum tax rules
Artificial intelligence in this business: Mentioned
How the score adds up
| Starting point | 60 | |
| Business momentum | −3 | |
| Outlook | 0 | |
| Tone against the previous report | +2 | |
| Financial stress | 0 | |
| Red flags | −3.6 | |
| New risks | −2 | |
| Score | 53 | |
Written by AI (Claude Opus 5.5) from the report’s text. 15 of 15 quotes were found word for word in the filing; the rest are left out. Not investment advice.
All scored reports
| Period | Report | Filed | Score | Momentum | Red flags |
|---|---|---|---|---|---|
| 10-Q | Oct 30, 2026 | Pro | |||
| 10-K | Feb 26, 2026 | 53 | Mixed | 2 medium | |
| 10-K | Feb 27, 2025 | 37 | Sharp deterioration | 1 medium1 minor | |
| 10-K | Feb 28, 2024 | 74 | Strong improvement | 1 medium | |
| 10-K | Feb 24, 2023 | 46 | Sharp deterioration | None | |
| 10-K | Feb 28, 2022 | 75 | Strong improvement | None | |
| 10-K | Mar 1, 2021 | 37 | Sharp deterioration | 1 medium | |
| 10-K | Mar 2, 2020 | 76 | Strong improvement | None | |
| 10-K | Mar 1, 2019 | 45 | Sharp deterioration | 1 medium | |
| 10-K | Mar 1, 2018 | 45 | Sharp deterioration | None |
How these scores work
An AI model reads the management discussion, risk factors and legal sections of each report and records what they say, quoting the filing word for word. Fixed rules then turn those findings into a score from 0 to 100, where 60 means nothing notable either way. A score describes the report, not whether the stock is a good investment, and the AI may know how things turned out later, which can colour older scores. Read the methodology
From the 10-Q for Q3 FY2026 (period ended Sep 30, 2026), filed Oct 30, 2026. View filings on SEC EDGAR